English

Massive Selection for Doxycycline Hyclate 100mg Sinus Infection - Sofosbuvir – CPF

Massive Selection for Doxycycline Hyclate 100mg Sinus Infection - Sofosbuvir – CPF Featured Image
  • Massive Selection for Doxycycline Hyclate 100mg Sinus Infection - Sofosbuvir – CPF

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We also offer you product sourcing and flight consolidation expert services. We've our personal manufacturing unit and sourcing business. We can offer you virtually every variety of merchandise associated to our item range for Canagliflozin Adverse Effects, Pms Hydrochlorothiazide, Doxycycline Mono Uses, Should further information be required, please contact us at any time!
Massive Selection for Doxycycline Hyclate 100mg Sinus Infection - Sofosbuvir – CPF Detail:

索非布韦 Sofosbuvir 1190307-88-0 In-House
    SFBM 1256490-31-9 In-House
    SFB-8 874638-80-9 In-House
    SFB-10 817204-32-3 In-House
    SFBA-1 863329-66-2 In-House
    SFBMA 1334513-02-8 In-House

Generic Name: sofosbuvir (soe FOS bue vir)
Brand Names: Sovaldi

Sofosbuvir is an antiviral medicine that is used to treat chronic hepatitis C in adults and children who are at least 3 years old and an HCV RNA replication inhibitor with an EC50 of 92 nM.

Sofosbuvir must be given in combination with other antiviral medications (usually ribavirin with or without peginterferon alfa). Sofosbuvir should not be used alone.

Sofosbuvir treats specific genotypes of hepatitis C, and only in certain people. Use only the medications prescribed for you. Do not share your medicine with other people.

Sofosbuvir is sometimes used in people who also have HIV, or people who have liver cancer and are going to have a liver transplant. This medicine is not a treatment for HIV or AIDS.

Storage

Powder

-20°C

 3 years

4°C

 2 years
In solvent

-80°C

 6 months

-20°C

 1 month

Chemical structure

Sofosbuvir

2018 GMP-2
原料药GMP证书201811（captopril ,thalidomide etc）
GMP-of-PMDA-in-Chanyoo-平成28年08月03日　Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

OUR STRENGTH

Quality management1

Proposal 18 Quality Consistency Evaluation projects which have approved 4, and 6 projects are under approving.

Quality management2

Advanced international quality management system has laid solid foundation for sales.

Quality management3

Quality supervision runs through the whole life cycle of the product to ensure the quality and therapeutic effect. 

Quality management4

Professional Regulatory Affairs team supports the quality demands during the application and registration.


VIEW MORE


VIEW MORE

International cooperation
International cooperation
Domestic cooperation
Domestic cooperation

Product detail pictures:

Massive Selection for Doxycycline Hyclate 100mg Sinus Infection - Sofosbuvir – CPF detail pictures

Related Product Guide:
Our development depends on the advanced equipment, excellent talents and continuously strengthened technology forces for Massive Selection for Doxycycline Hyclate 100mg Sinus Infection - Sofosbuvir – CPF , The product will supply to all over the world, such as: Jordan, Malawi, Frankfurt, Our business activities and processes are engineered to make sure our customers have access to widest range of products with the shortest supply time lines. This achievement is made possible by our highly skilled and experienced team. We look for people who want to grow with us around the globe and stand out from the crowd. We now have people who embrace tomorrow, have vision, love stretching their minds and going far beyond what they thought was achievable.
    • Good quality, reasonable prices, rich variety and perfect after-sales service, it's nice!
    5 Stars By Michaelia from Switzerland - 2017.11.20 15:58
    We have been cooperated with this company for many years, the company always ensure timely delivery ,good quality and correct number, we are good partners.
    5 Stars By Emma from Afghanistan - 2018.11.02 11:11
    Write your message here and send it to us

    Products categories